ЛЕТАЛЬНЫЙ СЛУЧАЙ ОТ ИНСУЛЬТА У БОЛЬНОГО COVID-19
COVID-19 - тяжелая острая респираторная инфекция, вызываемая новым вирусом SARS-CoV-2, летальность при которой может быть обусловлена как основным заболеванием, так и тяжелыми коморбидными заболеваниями. В статье представлен анализ клинического случая инсульта у больного COVID-19, приведший к летальному исходу. Проведен ретроспективный анализ истории болезни. Показано, что вирус COVID-19 может оказывать неблагоприятное воздействие на течение тяжелых коморбидных заболеваний у пациента и обуславливать неблагоприятный летальный исход.
Сауле Б. Маукаева1, Алма З. Токаева1, Жанар Б. Исабекова1, Ербол М. Смаил1, Гульнар И. Нуралинова1, Варвара А. Тренина1, Алия Ж. Киебаева1, Сая С. Каримова1, Султанбек Н. Битимиров1, Ерсин Т. Жунусов1 НАО «Медицинский университет Семей», г. Семей, Республика Казахстан
1. Клинический протокол РЦРЗ МЗ «Коронавирусная инфекция» 7-я редакция от 06.05.2020г. [Clinical protocol of the RCDH of the Ministry of Health “Coronavirus infection” 7th edition of 05.06.2020] URL: https://diseases.medelement.com/disease/коронавирусная-инфекция-2019-ncov-кп-мз-рк/16390 [Дата обращения: 24.05.2020г.] [in Russian] 2. Adams M.L., Katz D.L., Grandpre J. Population-based estimates of chronic conditions affecting risk for complications from coronavirus disease, United States // Emerg Infect Dis. 2020 Apr 23;26(8). 3. Aggarwal G., Cheruiyot I., Aggarwal S. et al. Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) severity: a meta-analysis // Curr Probl Cardiol. 2020 Apr 28:100617. 4. AHA/ASA Stroke Council Leadership. Temporary emergency guidance to US stroke centers during the COVID-19 pandemic. Stroke. 2020 Apr 1. [Epub ahead of print]. https://www.ahajournals.org/doi/10.1161/STROKEAHA.120.030023 [Дата обращения: 26.05.2020г.]. 5. CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19): United States, February 12 - March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-6. 6. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): people who are at higher risk for severe illness. 2020 [internet publication]. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html. [Дата обращения: 25.05.2020г.]. 7. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 // Nat Microbiol. 2020 Apr;5(4):536-44. 8. Docherty A.B., Harrison E.M., Green C.A., et al; medRxiv. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. 2020 [internet publication]. https://www.medrxiv.org/content/10.1101/2020.04.23.20076042v1 [Дата обращения: 26.05.2020г]. 9. Emami A., Javanmardi F., Pirbonyeh N., et al. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis // Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. 10-24. Filatov A., Sharma P., Hindi F., et al. Neurological complications of coronavirus disease (COVID-19): encephalopathy // Cureus. 2020 Mar 21;12(3):e7352. 11. Goyal P., Choi J.J., Pinheiro L.C., et al. Clinical characteristics of Covid-19 in New York City // N Engl J Med. 2020 Apr 17 [Epub ahead of print]. https://www.nejm.org/doi/full/10.1056/NEJMc2010419 [Дата обращения: 26.05.2020г.]. 12. Jin H., Hong C., Chen S., et al. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists // Stroke Vasc Neurol. 2020 Apr 1 [Epub ahead of print]. https://covid19.tabipacademy.com/wp-content/uploads/2020/05/Consensus-for-prevention-and-management-of-coronavirus-disease-2019-COVID-19-for-neurologists.pdf. [Дата обращения: 26.05.2020г.]. 13. Lusignan S. Dorward J., Correa A., et al. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study // Lancet Infect Dis. 2020 May 15 [Epub ahead of print]. https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(20)30371-6.pdf [Дата обращения: 25.05.2020г.]. 14. Mao L. Jin H., Wang M., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China // JAMA Neurol. 2020 Apr 10 [Epub ahead of print]. https://jamanetwork.com/journals/jamaneurology/fullarticle/2764549 [Дата обращения: 26.05.2020г.]. 15. Mao L., Wang M., Chen S., et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. 2020 [internet publication]. https://www.medrxiv.org/content/10.1101/2020.02.22.20026500v1 [Дата обращения: 26.05.2020г.]. 16. Montopoli M., Zumerle S., Vettor R., et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) // Ann Oncol. 2020 May 4 [Epub ahead of print]. https://www.researchgate.net/publication/330361371_Androgen_deprivation_therapy_for_prostate_cancer_and_risk_of_dementia [Дата обращения: 26.05.2020г.]. 17. Moriguchi T., Harii N., Goto J., et al. A first case of meningitis/encephalitis associated with SARS-coronavirus-2 // Int J Infect Dis. 2020 Apr 3;94:55-8. 18. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China [in Chinese]. 2020 Feb 17;41(2):145-51. 19. Poyiadji N., Shahin G., Noujaim D., et al. COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features // Radiology. 2020 Mar 31:201187. 20. Pranata R., Lim M.A., Huang I., et al. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression // J Renin Angiotensin Aldosterone Syst. 2020 Apr-Jun;21(2):1470320320926899. 21. Richardson S., Hirsch J.S., Narasimhan M., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area // JAMA. 2020 Apr 22 [Epub ahead of print]. https://jamanetwork.com/journals/jama/fullarticle/2765184. [Дата обращения: 26.05.2020г.]. 22. Shen N. Zhu Y., Wang X., et al. Characteristics and diagnosis rate of 5,630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China // JCI Insight. 2020 Apr 30 [Epub ahead of print]. URL: https://insight.jci.org/articles/view/137662. [Дата обращения: 25.05.2020г.]. 23. World Health Organization. Global surveillance for COVID-19 caused by human infection with COVID-19 virus. 2020 [internet publication]. URL: https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov). [Дата обращения: 24.05.2020г.]. 24. Zeng F., Dai C., Cai P., et al. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex // J Med Virol. 2020 May 8 [Epub ahead of print]. https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.25989. [Дата обращения: 25.5.2020г.]. 25. Zheng Z., Peng F., Xu B., et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis // J Infect. 2020 Apr 23 [Epub ahead of print]. https://www.journalofinfection.com/article/S0163-4453(20)30234-6/pdf. [Дата обращения: 25.05.2020г.].
Количество просмотров: 568

Ключевые слова:

Библиографическая ссылка

Маукаева С.Б., Токаева А.З., Исабекова Ж.Б., Смаил Е.М., Нуралинова Г.И., Тренина В.А., Киебаева А.Ж., Каримова С.С., Битимиров С.Н., Жунусов Е.Т. Летальный случай от инсульта у больного COVID-19 // Наука и Здравоохранение. 2020. 3(Т.22). С. 26-31. doi 10.34689/SH.2020.22.3.005

Авторизируйтесь для отправки комментариев